Meet Our Board
Kester Capital is an experienced life science services investor and has successfully invested in numerous CROs over the past decade. Now backing the Evestia Clinical team, they will enable the organization to scale rapidly, both organically and through acquisitions.
With decades of combined experience, our board aims to broaden its range of customized and tailored service capabilities, enhance our technology base, and strengthen our presence in global markets, including North America and Europe.
We will continue to deliver high-quality clinical solutions and clear customer focus while addressing unmet needs and current medical industry focuses — including oncology, neurology, rare diseases, inflammation, immunology, and microbiome therapeutics.
Experience You Can Trust
When the stakes are high, you need authentic, focused expertise you can trust. With decades of collective experience in oncology and rare diseases, we help you navigate the unknown with precision, strategy, and confidence. We operate only where we excel, ensuring that every project benefits from our uniquely in-depth insight and unwavering attention to detail.
When every decision matters, we make sure you get them right.
Partner With Us
When every decision matters, we make sure you get it right.
